Effect of Probiotics on Lipid Management

Status Active, not recruiting

Clinical Trial Summary

Dysbiosis of gut microbiota has been reported to be involved in the development of hypercholesterolemia in both humans and animal models. Probiotics have been reported to have ameliorative effects in murine models. However, whether probiotics could help alleviate dyslipidemia in adults remain obscure.

Clinical Trial Description

Probiotics are live microorganisms that have been associated with multiple health benefits. However, its protective role in adults has long been controversial. This study aims to examine the effect of 12-week probiotics supplementation on lipid management in Chinese adults. By understanding the mechanism by which probiotics exert the beneficial effects, we can better control the rising prevalence of hypercholesterolemia, which is a major risk factor for cardiovascular diseases. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03952169
Study type	Interventional
Source	Sun Yat-sen University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	May 12, 2019
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05559606` - An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Completed	`NCT03571087` - Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia	Phase 3
Completed	`NCT00776321` - Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia	Phase 2
Recruiting	`NCT05399992` - Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD
Withdrawn	`NCT05798390` - Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia
Completed	`NCT06448962` - Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022	Phase 3
Completed	`NCT00724477` - Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)
Completed	`NCT00249249` - Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels	Phase 3
Recruiting	`NCT05657574` - A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia	Phase 3
Completed	`NCT02941848` - Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers	Phase 1
Completed	`NCT03516955` - Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting
Completed	`NCT01012219` - A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)	Phase 1
Completed	`NCT05131997` - A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A	Phase 3
Terminated	`NCT03433755` - Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia	Phase 3
Completed	`NCT00867165` - Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)	Phase 3
Not yet recruiting	`NCT06386419` - A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia	Phase 4
Terminated	`NCT01335997` - Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)	Phase 3
Completed	`NCT02087917` - A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia	Phase 2
Completed	`NCT00704535` - Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)
Recruiting	`NCT06314919` - A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib